A group of 34 earned their short white coats as the newest class in Weill Cornell Medicine’s Master of Science in Health Sciences for Physician Assistants program.
Non-white communities had significantly less access to opioid medications commonly prescribed for moderate to severe pain than white communities over the decade beginning in 2011, according to a study by Weill Cornell Medicine researchers.
The overwhelming majority of those in New York City who obtained a naloxone kit to counteract opioid overdose had a high need for the drug, according to a new study by Weill Cornell Medicine investigators.
Dr. Jim Castellanos, Ph.D. ’18, M.D. ’20, an instructor in anesthesiology at Weill Cornell Medicine, has been selected as a 2024 Hanna H. Gray Fellow by the Howard Hughes Medical Institute.
People with diabetes who were taking GLP-1 receptor agonist drugs had significantly lower rates of hospital readmission, wound reopening and hematoma after surgery, according to new study.
The hormone estrogen regulates binge drinking in females, causing them to “pregame” – consume large quantities of alcohol in the first 30 minutes after it’s offered, according to a preclinical study led by scientists at Weill Cornell Medicine.
A Cornell Tech-led research group is in the early stages of developing a portable, inexpensive device that uses radio frequency signals and machine learning to measure lead contamination levels in soil.
Prostate cancer hijacks the normal prostate’s growth regulation program to release the brakes and grow freely, according to Weill Cornell Medicine researchers.
